Approval · Notice of Compliance 22269 · 2019
SELEXID: Notice of Compliance 22269
Issued June 12, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22269
- Date
- June 12, 2019
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
Medicinal ingredients
- PIVMECILLINAM HCL 200 MG per TAB
- PIVMECILLINAM HCL 400 MG per TAB